Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer’s Disease Pathogenesis—From Gut Microbiota and Viruses to Brain Biofilms
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(1), P. 90 - 90
Published: Jan. 5, 2025
For
decades,
Alzheimer's
Disease
(AD)
research
has
focused
on
the
amyloid
cascade
hypothesis,
which
identifies
amyloid-beta
(Aβ)
as
primary
driver
of
disease.
However,
consistent
failure
Aβ-targeted
therapies
to
demonstrate
efficacy,
coupled
with
significant
safety
concerns,
underscores
need
rethink
our
approach
AD
treatment.
Emerging
evidence
points
microbial
infections
environmental
factors
in
pathoetiology.
Although
a
definitive
causal
link
remains
unestablished,
collective
is
compelling.
This
review
explores
unconventional
perspectives
and
emerging
paradigms
regarding
involvement
pathogenesis,
emphasizing
gut-brain
axis,
brain
biofilms,
oral
microbiome,
viral
infections.
Transgenic
mouse
models
show
that
gut
microbiota
dysregulation
precedes
Aβ
accumulation,
signaling
pathways.
Viral
like
Herpes
Simplex
Virus
Type
1
(HSV-1)
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
may
lead
by
modulating
host
processes
immune
system.
peptide's
antimicrobial
function
response
infection
might
inadvertently
promote
AD.
We
discuss
potential
microbiome-based
promising
strategies
for
managing
potentially
preventing
progression.
Fecal
transplantation
(FMT)
restores
balance,
reduces
improves
cognition
preclinical
models.
Probiotics
prebiotics
reduce
neuroinflammation
plaques,
while
antiviral
targeting
HSV-1
vaccines
shingles
vaccine
mitigate
pathology.
Developing
effective
treatments
requires
standardized
methods
identify
measure
patients,
enabling
personalized
address
individual
contributions
pathogenesis.
Further
needed
clarify
interactions
between
microbes
Aβ,
explore
bacterial
interplay,
understand
their
broader
effects
translate
these
insights
into
clinical
interventions.
Language: Английский
Identification of therapeutic targets for Alzheimer’s Disease Treatment using bioinformatics and machine learning
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 31, 2025
Alzheimer's
disease
(AD)
is
a
complex
neurodegenerative
disorder
that
currently
lacks
effective
treatment
options.
This
study
aimed
to
identify
potential
therapeutic
targets
for
the
of
AD
using
comprehensive
bioinformatics
methods
and
machine
learning
algorithms.
By
integrating
differential
gene
expression
analysis,
weighted
co-expression
network
Mfuzz
clustering,
single-cell
RNA
sequencing,
algorithms
including
LASSO
regression,
SVM-RFE,
random
forest,
five
hub
genes
related
AD,
PLCB1,
NDUFAB1,
KRAS,
ATP2A2,
CALM3
were
identified.
in
particular,
exhibited
highest
diagnostic
value
showed
significant
correlation
with
Braak
stages
neuronal
expression.
Furthermore,
Noscapine,
PX-316,
TAK-901
selected
as
drugs
based
on
PLCB1.
research
provides
reliable
method
discovery
construction
models,
offering
important
insights
directions
future
strategies
drug
development.
Language: Английский
APOE ε4–associated downregulation of the IL‐7/IL‐7R pathway in effector memory T cells: Implications for Alzheimer's disease
Alzheimer s & Dementia,
Journal Year:
2024,
Volume and Issue:
20(9), P. 6441 - 6455
Published: Aug. 11, 2024
Abstract
INTRODUCTION
The
apolipoprotein
E
(
APOE
)
ε4
allele
exerts
a
significant
influence
on
peripheral
inflammation
and
neuroinflammation,
yet
the
underlying
mechanisms
remain
elusive.
METHODS
present
study
enrolled
54
patients
diagnosed
with
late‐onset
Alzheimer's
disease
(AD;
including
28
carriers
26
non‐carriers).
Plasma
inflammatory
cytokine
concentration
was
assessed,
alongside
bulk
RNA
sequencing
(RNA‐seq)
single‐cell
(scRNA‐seq)
analysis
of
blood
mononuclear
cells
(PBMCs).
RESULTS
tumor
necrosis
factor
α,
interferon
γ,
interleukin
(IL)‐33
levels
increased
in
but
IL‐7
expression
notably
decreased.
A
negative
correlation
observed
between
plasma
level
hippocampal
atrophy
degree.
Additionally,
IL‐7R
CD28
also
decreased
PBMCs
carriers.
ScRNA‐seq
data
results
indicated
that
changes
were
mainly
related
to
CD4+
Tem
(effector
memory)
CD8+
T
cells.
DISCUSSION
These
findings
shed
light
role
downregulated
IL‐7/IL‐7R
pathway
associated
modulating
neuroinflammation
atrophy.
Highlights
decreases
(IL)‐7
aggravates
disease.
is
negatively
degree
signaling
Dysregulation
signal
pathways
enriches
Language: Английский
Single-cell and spatial analysis reveals the interaction between ITLN1+ foam cells and SPP1+ macrophages in atherosclerosis
Frontiers in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: Feb. 13, 2025
Introduction
Cardiovascular
disease
(CVD)
caused
by
atherosclerosis
(AS)
remains
the
leading
cause
of
mortality
in
developed
countries.
Understanding
cellular
heterogeneity
within
inflammatory
microenvironment
is
crucial
for
advancing
management
strategies.
This
study
investigates
regulatory
functions
distinct
cell
populations
AS
pathogenesis,
focusing
on
interaction
between
vascular
smooth
muscle
(VSMC)-derived
ITLN1
+
foam
cells
and
SPP1
FABP5
macrophages.
Methods
We
employed
single-cell
RNA
sequencing
to
characterize
plaques.
Correlation
analyses
CellChat
package
were
utilized
elucidate
intercellular
communication
networks
among
various
types.
The
functional
roles
key
subsets
macrophages
VSMCs
assessed
using
Gene
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
analyses.
Pseudotime
trajectory
analysis
was
conducted
explore
dynamics
VSMC
differentiation.
Additionally,
spatial
transcriptomics
used
demonstrate
physical
interactions
different
subpopulations.
Results
identified
significant
infiltration
macrophage
clusters
AS,
with
being
highly
enriched
These
associated
lipid
transport,
storage,
migration
pathways.
A
subset
derived
from
exhibited
robust
expression
markers
metabolism-related
genes.
indicated
that
represent
a
terminal
stage
differentiation,
characterized
elevated
genes
linked
synthesis
progression.
Spatial
revealed
macrophages,
mediated
MIF-(CD74
CD44)
SPP1-CD44
ligand-receptor
axes.
Discussion
Our
findings
underscore
critical
crosstalk
promoting
accumulation
Targeting
this
cell-cell
may
offer
new
therapeutic
avenues
managing
atherosclerosis.
Further
validation
these
mechanisms
necessary
develop
effective
immunotherapeutic
strategies
against
AS.
Language: Английский
Association between plasma cytokine levels and multiple neuroimaging modalities in mild cognitive impairment
Atsuhito Nakamichi,
No information about this author
Noriyuki Kimura,
No information about this author
Takuya Hanaoka
No information about this author
et al.
Journal of Alzheimer s Disease,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 16, 2025
Background
The
relationship
between
peripheral
cytokines
and
neuroimaging
biomarkers
for
Alzheimer's
disease
(AD)
is
not
yet
well
established.
Objective
To
determine
the
association
of
cytokine
plasma
levels
with
brain
amyloid
deposition,
cortical
glucose
metabolism,
hippocampal
volume,
white
matter
lesions
(WMLs)
in
older
adults
mild
cognitive
impairment
(MCI).
Methods
We
recruited
50
individuals
amnestic
MCI
(25
men
25
women;
median
age,
75
years)
performed
analysis,
11
C-Pittsburgh
compound-B
positron-emission
tomography
(PiB-PET),
18
F-fluorodeoxyglucose
tomography,
magnetic
resonance
imaging.
Global
PiB
fluorodeoxyglucose
(FDG)
uptake
were
assessed
by
ratio
voxel
number-weighted
average
mean
frontal,
temporoparietal,
posterior
cingulate,
reference
to
cerebellum.
Fazekas
scale
was
used
evaluate
WMLs.
Plasma
48
simultaneously
measured
bead-based
multiplex
assays.
Results
IL-2Ra,
IL-3,
IL-5,
IL-7,
IL-9,
IL-16,
IL-18,
fibroblast
growth
factor
(FGF-basic),
granulocyte
colony-stimulating
(G-CSF),
granulocyte–macrophage
(GM-CSF),
macrophage
inflammatory
protein-1α
(MIP-1α),
regulated
on
activation,
normal
T-cell
expressed
secreted
(RANTES),
tumor
necrosis
factor-α
(TNF-α),
cutaneous
attracting
chemokine
(CTACK),
growth-regulated
oncogene
α
(GROα),
hepatocyte
(HGF),
interferon-α2
(IFN-α2),
leukemia
inhibitory
(LIF),
monocyte
chemoattractant
protein-3
(MCP-3),
β-nerve
(β-NGF),
stem
cell
(SCF),
factor-β
(SCGF-β),
TNF-related
apoptosis-inducing
ligand
(TRAIL)
significantly
associated
global
uptake,
whereas
those
IL-7
GROα
volume
after
covariate
adjustment
false
discovery
rate
correction.
Conclusions
are
deposition
rather
than
dysfunction
or
atrophy.
Moreover,
may
play
important
roles
early-stage
AD
pathophysiology.
Language: Английский
The effect of C-reactive protein and interleukin-3 on mild cognitive impairment with APOE ɛ4
Xinyi Yang,
No information about this author
Lei Chi,
No information about this author
Meizhao Qiao
No information about this author
et al.
Journal of Alzheimer s Disease,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 22, 2025
Background
The
apolipoprotein
E
ε4
allele
(
APOE
ε4)
and
inflammation
are
associated
with
Alzheimer's
disease
(AD)
pathology.
Mild
cognitive
impairment
(MCI)
is
considered
the
preclinical
early
stage
of
AD.
However,
comprehensive
effects
inflammatory
mediators
on
MCI
patients
specific
genotypes
remain
poorly
understood.
Objective
Our
study
aimed
to
explore
how
different
numbers
alleles
affect
plasma
C-reactive
protein
(CRP)
interleukin-3
(IL-3)
levels
their
associations
brain
structure.
Methods
A
total
339
from
Disease
Neuroimaging
Initiative
were
enrolled.
We
compared
concentrations
CRP
IL-3,
performance,
cerebrospinal
fluid
(CSF)
AD
biomarkers
across
genotypes.
Structural
magnetic
resonance
imaging
was
utilized
measure
gray
matter
volume
outcomes.
Pearson
correlation
analysis
used
between
above
indicators.
Results
Plasma
increased
in
carriers,
but
IL-3
expression
notably
decreased,
homozygous
state
most
significant.
negative
several
abilities
observed
only
homozygotes.
Additionally,
a
positive
scores,
CSF
biomarker
confirmed
Imaging
data
demonstrated
that
right
middle
frontal
gyrus
non-carriers.
Conclusions
peripheral
mediators’
effect
function
structure
differs
based
carrier
status.
Language: Английский